We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First Patients are Vaccinated in IMPRINT, immatics’ Pivotal Phase III Trial with IMA901 in Patients with RCC

Product News   Jun 16, 2011

 
First Patients are Vaccinated in IMPRINT, immatics’ Pivotal Phase III Trial with IMA901 in Patients with RCC
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Ceryx Medical Appoints Chas Taylor as Chairman

Product News

Chas Taylor has been appointed as Chairman at Ceryx Medical. Taylor brings with him decades of experience in developing and leading medical device companies.

READ MORE

Formedix Launches All-In-One Cloud-Based Clinical Metadata Repository and Study Automation Platform

Product News

Formedix announces the launch of ryze, an all-in-one cloud-based clinical metadata repository (MDR) and study automation platform. ryze has been specifically developed to accelerate and streamline the design, build and submission of clinical trials.

READ MORE

Albumedix and FUJIFILM Wako Partner To Strengthen Advanced Therapy Efforts

Product News

Albumedix Ltd have announced that they have entered into a distribution agreement with FUJIFILM Wako in Japan and China including Hong Kong. The partnership further strengthens Albumedix’ commitment to advanced therapy and biopharmaceutical developers in the region.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE